Welcome to our dedicated page for Rocket Doctor AI news (Ticker: AIRDF), a resource for investors and traders seeking the latest updates and insights on Rocket Doctor AI stock.
Rocket Doctor AI Inc. (AIRDF) is a healthcare technology company that reports on developments at the intersection of artificial intelligence and digital health. Company news frequently highlights its physician-built Global Library of Medicine (GLM), an AI-powered clinical decision support system, and the activities of its wholly owned digital health platform and marketplace, Rocket Doctor Inc.
Investors and observers following AIRDF news can read about partnerships, technology rollouts, and corporate milestones. Recent announcements have covered collaborations with organizations such as the CAN Health Network and Health Cities in Alberta to pilot an AI-powered Clinical Decision Support System, as well as a strategic partnership between Rocket Doctor Inc. and Toronto Metropolitan University to expand clinical education opportunities on a digital health platform. The company also publishes updates on its U.S. expansion, including payer credentialing and leadership appointments to support growth across multiple states.
Rocket Doctor AI’s news flow includes information on product development, such as enhancements to its GLM, Starship EMR, RD Connect, and RD Health Voyager tools, along with initiatives like pharmacy-based virtual care programs and emergency department diversion efforts. Corporate and capital markets updates, including private placements, analyst coverage arrangements, and grants of restricted share units and stock options, are also disclosed through news releases.
This news page aggregates these company-issued updates in one place, allowing readers to follow how Rocket Doctor AI is applying AI-powered clinical decision support, virtual care technology, and partnerships with healthcare and academic institutions. For those tracking AIRDF, the news feed provides context on how the company describes its strategy, technology evolution, and market initiatives over time.
Rocket Doctor AI (OTC:AIRDF) engaged FN Media Group for a three-day news and digital media marketing campaign starting the week of October 20, 2025 for USD $14,085.
FN Media will use its proprietary traffic application plus Google/Yahoo digital ads. The firm and its directors do not own any interest in Rocket Doctor AI and are described as arm’s length. FN Media contact details and address are provided in the announcement.
Rocket Doctor AI (OTC: AIRDF) announced that its U.S. subsidiary Treatment.com, together with Rush River Research, received a US $2.0 million NIH SBIR Phase II grant awarded by the National Institute on Minority Health and Health Disparities.
The two-year award advances an AI-powered, culturally sensitive family medical history tool, provides Treatment with over $500,000 to enhance its Global Library of Medicine (GLM), and supports commercialization and integration across commercial platforms with usability and community testing focused initially on African-American communities.
Rocket Doctor AI (OTCQB: AIRDF), a healthcare technology company, will present at the 2025 CANTech Letter Conference in Toronto on October 9, 2025. CEO Dr. Essam Hamza and Rocket Doctor Inc. Founder Dr. William Cherniak will deliver their presentation at 2:30 PM ET in Track 1.
The presentation will showcase the company's AI-powered healthcare platform, which focuses on improving healthcare accessibility and patient outcomes through streamlined workflows and reduced administrative friction. The company's leadership will discuss their platform innovations, recent milestones, and growth strategy.